Lung Disease & Respiratory Health Center

Citations

1. Niederman MS (2004). Pneumonia, including community-acquired and nosocomial pneumonia. In JD Crapo et al., eds., Baum's Textbook of Pulmonary Diseases, 7th ed., vol. 1, pp. 424–454. Philadelphia: Lippincott Williams and Wilkins.

2. File TM Jr (2003). Community-acquired pneumonia. Lancet, 362(9400): 1991–2001.

3. Laheij RJF, et al. (2004). Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA, 292(16): 1955–1960.

4. Herzig SJ, et al. (2009). Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA, 301(20): 2120–2128.

5. Loeb M (2010). Community-acquired pneumonia, search date January 2010. Online version of BMJ Clinical Evidence: http://www.clinicalevidence.com.

6. Moberley SA, et al. (2008). Vaccines for preventing pneumococcal infection in adults. Cochrane Database of Systematic Reviews(1). Oxford: Update Software.

7. Maruyama T, et al. (2010). Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: Double blind, randomised and placebo controlled trial. BMJ. Published online March 8, 2010 (doi: 10.1136/bmj.c1004).

8. Arnold FW, et al. (2009). Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Archives of Internal Medicine, 169(16): 1515–1524.

9. McCabe C, et al. (2009). Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: Playing by the rules. Archives of Internal Medicine, 169(16): 1525–1531.

Other Works Consulted

• Murray MT, Bongiorno PB (2006). Pneumonia: Bacterial, mycoplasmal, and viral. In JE Pizzorno Jr, MT Murray, eds., Textbook of Natural Medicine, 3rd ed., vol. 2, pp. 2039–2044. Edinburgh: Churchill Livingstone.

• Torres A, et al. (2010). Pyogenic bacterial pneumonia and lung abscess. In R Mason et al., eds., Murray and Nadel's Textbook of Respiratory Medicine, 5th ed., vol. 1, pp. 699–740. Philadelphia: Saunders.

• Centers for Disease Control and Prevention (2010). Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR, 59(34): 1102–1106. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5934a3.htm?s_cid=mm5934a3_e.

• Centers for Disease Control and Prevention (2010). Prevention of pneumococcal disease among infants and children: Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 59(RR-11): 1–18. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5911.pdf.

• Centers for Disease Control and Prevention (2011). Recommended adult immunization schedule-United States, 2011. MMWR, 60(04): 1–4. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6004a10.htm?s_cid=mm6004a10_e&source=govdelivery.

• Fiebach NH, Barr RG (2007). Respiratory tract infections. In NH Fiebach et al., eds., Principles of Ambulatory Medicine. 7th ed., pp. 474–500. Philadelphia: Lippincott Williams and Wilkins.

• Mandell LA, et al. (2007). Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clinical Infectious Diseases, 44(Suppl 2): S27-S72.

• Musher DM (2010). Streptococcus pneumoniae. In GL Mandell et al., eds., Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed., vol. 2, pp. 2623–2642. Philadelphia: Churchill Livingstone Elsevier.